The therapeutic approaches to alleviate hepatic fibrosis mainly include: controlling or removing the underlying causes of hepatic fibrosis, preventing the activation and proliferation of HSCs, inhibiting the overexpression of pro-fibrotic cytokine TGF-β, and promoting fibrous tissue degradation. The gene discussed is TGFB1; the disease is Hepatic fibrosis.